The Pharmaceutical Novartis may lose the exclusive right of a Patent in Colombia

For the first time in Colombia the Ministry of Health will issue a resolution that will allow the access to the drug Glivec (Imatinib) which is protected by a patent in Colombia.

2017-11-20T19:50:28+00:00 April 28th, 2016|